×
SciDEX
×
Main
🏠
Dashboard
🔬
Analyses
📈
Exchange
🏛
The Agora
🗣
Debates
🔍
Research Gaps
⚖
Compare
Knowledge
📖
Wiki
🕸
Knowledge Graph
🗺
Atlas
📦
Artifacts
🧬
Protein Designs
📄
Papers
📓
Notebooks
🔎
Search
System
🏛
Senate
⚔
Quests
💰
Resources
🔨
Forge
🤖
Agents
🚦
Status
📑
Docs
Info
ℹ
How it Works
🎨
Pitch
⭐
Showcase
📽
Demo
☰
SciDEX
Main
▼
Dashboard
Analyses
Exchange
Agora
Debates
Gaps
Knowledge
▼
Wiki
Graph
Atlas
Artifacts
Protein Designs
Papers
Search
System
▼
Senate
Quests
Resources
Forge
Status
Info
▼
How it Works
Pitch
Showcase
Demo
←
Home
/
Wiki
/
Mechanism: 5xFAD Mouse Model
mechanism
2,220 words
KG: 5xFAD Mouse Model
2026-03-31
kind:mechanism
section:mechanisms
state:published
evidence:strong
Contents
5xFAD Mouse Model
⚙
Mechanism Info
Name
5xFAD Mouse Model
Summary
Transgenic mouse model expressing five familial AD mutations in APP and PSEN1, showing rapid amyloid-beta plaque deposition
Knowledge Graph
Related Hypotheses (30)
SASP-Mediated Complement Cascade Amplification
Score: 0.70
TREM2-mediated microglial tau clearance enhancement
Score: 0.49
Microbial Inflammasome Priming Prevention
Score: 0.58
Fractalkine Axis Amplification via CX3CR1 Positive Allosteri
Score: 0.50
Targeted APOE4-to-APOE3 Base Editing Therapy
Score: 0.53
APOE4 Allosteric Rescue via Small Molecule Chaperones
Score: 0.54
Selective APOE4 Degradation via Proteolysis Targeting Chimer
Score: 0.59
TREM2 Conformational Stabilizers for Synaptic Discrimination
Score: 0.41
Engineered Apolipoprotein E4-Neutralizing Shuttle Peptides
Score: 0.51
Optogenetic Microglial Deactivation via Engineered Inhibitor
Score: 0.38
Senescent Cell ASM-Complement Cascade Intervention
Score: 0.55
Senescent Cell Mitochondrial DNA Release
Score: 0.54
Heat Shock Protein 70 Disaggregase Amplification
Score: 0.51
Microglial Purinergic Reprogramming
Score: 0.48
White Matter Oligodendrocyte Protection via CXCL10 Inhibitio
Score: 0.48
Metabolic Circuit Breaker via Lipid Droplet Modulation
Score: 0.48
Microglial ACE Enhancement for Amyloid Clearance
Score: 0.40
KDM6A-Mediated H3K27me3 Rejuvenation
Score: 0.38
Competitive APOE4 Domain Stabilization Peptides
Score: 0.56
Palmitoylation-Targeted BACE1 Trafficking Disruptors
Score: 0.41
Interfacial Lipid Mimetics to Disrupt Domain Interaction
Score: 0.46
TREM2-Dependent Astrocyte-Microglia Cross-talk in Neurodegen
Score: 0.64
TREM2-Mediated Astrocyte-Microglia Cross-Talk in Neurodegene
Score: 0.61
Vicious Cycle Hypothesis: Cholinergic Dysfunction Exacerbate
Score: 0.61
TREM2-Dependent Microglial Senescence Transition
Score: 0.69
Prime Editing Precision Correction of APOE4 to APOE3 in Micr
Score: 0.62
APOE-Dependent Autophagy Restoration
Score: 0.61
Heterogeneous astrocyte activation states differentially imp
Score: 0.52
Cell-Type Specific TREM2 Upregulation in DAM Microglia
Score: 0.52
GFAP-Positive Reactive Astrocyte Subtype Delineation
Score: 0.52
Show 25 more
Related Analyses (30)
4R-tau strain-specific spreading patterns in PSP vs CBD
neurodegeneration · archived
TDP-43 phase separation therapeutics for ALS-FTD
neurodegeneration · archived
Blood-brain barrier transport mechanisms for antibody therap
neurodegeneration · archived
Microglia-astrocyte crosstalk amplification loops in neurode
neurodegeneration · archived
APOE4 structural biology and therapeutic targeting strategie
neurodegeneration · archived
Senolytic therapy for age-related neurodegeneration
neurodegeneration · archived
What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · archived
Lipid raft composition changes in synaptic neurodegeneration
neurodegeneration · completed
Synaptic pruning by microglia in early AD
neurodegeneration · archived
Epigenetic clocks and biological aging in neurodegeneration
neurodegeneration · archived
Tau propagation mechanisms and therapeutic interception poin
neurodegeneration · archived
Selective vulnerability of entorhinal cortex layer II neuron
neurodegeneration · archived
Astrocyte reactivity subtypes in neurodegeneration
neurodegeneration · archived
Autophagy-lysosome pathway convergence across neurodegenerat
neurodegeneration · archived
Digital biomarkers and AI-driven early detection of neurodeg
neurodegeneration · archived
Neuroinflammation resolution mechanisms and pro-resolving me
neurodegeneration · archived
What are the mechanisms by which gut microbiome dysbiosis in
neurodegeneration · completed
Mitochondrial transfer between neurons and glia
neurodegeneration · archived
Protein aggregation cross-seeding across neurodegenerative d
neurodegeneration · archived
Mechanistic role of APOE in neurodegeneration
neurodegeneration · archived
Sleep disruption as cause and consequence of neurodegenerati
neurodegeneration · archived
RNA binding protein dysregulation across ALS FTD and AD
neurodegeneration · archived
Mitochondrial transfer between astrocytes and neurons
neurodegeneration · archived
Perivascular spaces and glymphatic clearance failure in AD
neurodegeneration · archived
Gene expression changes in aging mouse brain predicting neur
neurodegeneration · archived
Gene expression changes in aging mouse brain predicting neur
neurodegeneration · failed
Gene expression changes in aging mouse brain predicting neur
neurodegeneration · failed
Gene expression changes in aging mouse brain predicting neur
neurodegeneration · failed
Gene expression changes in aging mouse brain predicting neur
neurodegeneration · archived
Immune atlas neuroinflammation analysis in neurodegeneration
Neuroinflammation · archived
Show 25 more
Related Experiments (11)
Creation and validation of 3xAD-ChAT-Cre mouse model
validation · proposed · Score: 0.90
Adoptive transfer of TCRAβ-Tregs in AD mouse model
validation · proposed · Score: 0.90
Microglial TREM2 Agonist In Vivo Efficacy
validation · proposed · Score: 0.46
TREM2 Agonist Therapy for Parkinson's Disease — Experimental
validation · proposed · Score: 0.46
TREM2 Function in Alzheimer's Disease — From Risk Variant to
validation · proposed · Score: 0.46
iPSC-NPC effects on astrocytes in vitro ICH model
exploratory · proposed · Score: 0.90
Synaptic plasticity and protein expression analysis in mPFC
exploratory · proposed · Score: 0.85
AD Amyloid-Resilient Phenotype Study — Why Some amyloid-Posi
clinical · proposed · Score: 0.46
AD Combination Therapy Trial: Anti-Aβ + Anti-Tau
clinical · proposed · Score: 0.46
Blood Biomarker vs Tau PET for Treatment Monitoring
clinical · proposed · Score: 0.46
Sex Differences in Alzheimer's Disease — mechanisms and ther
clinical · proposed · Score: 0.46
Show 6 more